Find Jobs | Post Resume | my careerbuilder | Help
Employer Quick Look


HQ: Franklinton, NC   |  
Novozymes is the biotech-based world leader in enzymes and microorganisms. We strive towards better business, cleaner environment and better lives. Novozymes is the biotech-based world leader in enzymes and microorganisms. Using nature's own technologies, we continuously expand the frontiers of biological solutions to improve industrial performance in all areas.

Environment-friendly products
Novozymes' more than 600 products are a key player in the production of thousands of products you use in your everyday life - from the textiles in your clothes to the food you eat.

In more than 40 different industries and 130 countries, our biological solutions improve industrial performance and quality while at the same time saving on water, energy, raw materials and waste.

Solutions for the future
In partnership with customers, technology leaders and other stakeholders, Novozymes' 4,000 employees use nature's diversity and our advanced biotech platform to make these unique qualities available to businesses everywhere.
Career Opportunities
Novozymes to acquire Indian enzyme business

Novozymes acquires Biocon’s enzyme business for an agreed purchase price equivalent to DKK 551 million. Novozymes thereby strengthens its position in India.

Biocon is one of India's leading biotechnology companies, specialising in biopharmaceuticals, contract research, clinical research and enzymes. The company is the leading enzyme player in India, and the enzyme business includes a broad range of industrial enzymes, food additives and process aids. Further, Biocon holds a leading position in the global enzymes market for the juice and wine industries.

“The acquisition of Biocon’s enzyme business provides an important step for Novozymes in strengthening our position on the Indian market, which we believe has an attractive growth potential. The activities of Biocon have a good strategic fit to our existing enzyme business”, says CEO of Novozymes, Steen Riisgaard, “We see several interesting market opportunities combined with synergy potential, making this a very interesting acquisition“, he continues.
We imagine a future where our biological solutions create the necessary balance between better business, cleaner environment and better lives.
To get there:

  • We will drive a significant expansion of the market for industrial biotechnology with enzymes and micro organisms as our basis.

  • We will find new and improved solutions to serve the market for biopharmaceuticals.

  • We will achieve double digit growth with a leadership position in all markets served.

  • Customers and partners throughout the world will seek our collaboration because of what we do and how we do it.

  • People from all over the world will want to work for us because of what we do and how we do it.

  • Society will be inspired by our work to choose biological solutions as a key part of the future.